Antioxidant and Antiradical Activity of Drugs Intended for Treating Ophthalmic Disorders

A. V. Ivanova; E. L. Gerasimova; E. R. Gazizullina; Ya. A. Okulova; A. I. Matern; V. L. Rusinov

doi:10.1007/s11094-018-1883-5

Antioxidant and Antiradical Activity of Drugs Intended for Treating Ophthalmic Disorders

作者: Ivanova A.V.¹, Gerasimova E.L.¹, Gazizullina E.R.¹, Okulova Y.A.¹, Matern A.I.¹, Rusinov V.L.¹
隶属关系:
1. Institute of Chemical Technology, B. N. Yeltsin Ural Federal University
期: 卷 52, 编号 8 (2018)
页面: 694-699
栏目: Article
URL: https://journals.rcsi.science/0091-150X/article/view/245415
DOI: https://doi.org/10.1007/s11094-018-1883-5
ID: 245415

如何引用文章

全文:

开放存取

##reader.subscriptionAccessGranted##
受限制的访问

订阅存取

详细
作者简介
参考
补充文件
统计

详细

Dosage forms intended for ophthalmic use with declared and potential antioxidant properties were investigated. Antioxidant activity was determined using potentiometry with potassium hexacyanoferrate (III) as the oxidant. Antiradical activity was studied using the stable radical 2,2-diphenyl-1-picrylhydrazyl. The reaction half-lives of the investigated dosage forms were determined. Ratios of the experimental antioxidant activity to the content of main active ingredient were assessed.